Education
About Us
Working with TipRanks
Follow Us
Marianne De Backer Insider Profile
4 Followers
Marianne De Backer, Director at Arrowhead Pharmaceuticals, holds 822.62K shares in Vir Biotechnology (Ticker: VIR), holds 31.27K shares in Arrowhead Pharmaceuticals (Ticker: ARWR), holds 14.08K shares in Kronos Bio (Ticker: KRON). Most recently, Marianne De Backer Sold ― shares of Vir Biotechnology on Apr 04, 2025 for an estimated value of 473.49K.
Marianne De Backer Arrowhead Pharmaceuticals (ARWR)Director
Arrowhead Pharmaceuticals (ARWR)
Director
Ranked #14,808 out of 102,596 Corporate Insiders
Profitable Transactions
7 out of 10 Profitable Transactions
Average Return
+11.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Marianne De Backer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 24, 2020 - Jun 24, 2021
Return:+125.10%
The most profitable trade made by Marianne De Backer
Marianne De Backer's Trading History
Arrowhead Pharmaceuticals
Jan 11, 2023
Director
Uninformative Buy
―
$492.14K
Kronos Bio
Jun 29, 2022
―
Uninformative Buy
―
$12.39K
Vir Biotechnology
Apr 04, 2025
CEO, Director
Informative Sell
473.49K
$4.65M
List of latest transactions for each holding click on a transaction to see Marianne De Backer's performance on stock
You May Also Like
Marianne De Backer insider profile FAQ
What is the percentage of profitable transactions made by Marianne De Backer?
The percentage of profitable transactions made by Marianne De Backer is 70%.
What is the average return per transaction made by Marianne De Backer?
The average return per transaction made by Marianne De Backer is 11.70%.
What stocks does Marianne De Backer hold?
Marianne De Backer holds: ARWR, KRON, VIR stocks.
What was Marianne De Backer’s latest transaction?
Marianne De Backer latest transaction was an Informative Sell of $473.49K.
What was Marianne De Backer's most profitable transaction?
Marianne De Backer’s most profitable transaction was an Informative Buy of ARWR stock on June 24, 2020. The return on the trade was 125.10%.
What is Marianne De Backer's role in Arrowhead Pharmaceuticals?
Marianne De Backer's role in Arrowhead Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.